Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers


  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 33 articles:
HTML format

Single Articles

    December 2023
  1. D'IZARNY-GARGAS T, Isnard P, Boudhabhay I, Buob D, et al
    The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
    Kidney Int. 2023;104:1206-1218.
    PubMed     Abstract available

    November 2023
  2. WEI S, Su L, Gao Q
    Initiation of diuretics or calcium channel blockers on the top of renin-angiotensin system inhibitors on kidney outcome: which is better?
    Kidney Int. 2023;104:1036-1037.

    August 2023
  3. FINE LG
    The power of "negative" experiments: Harry Goldblatt's pathway to discovering how renal ischemia causes hypertension.
    Kidney Int. 2023;104:218-220.

  4. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.

    July 2023
  5. HONG S, Kim KS, Han K, Park CY, et al
    A cohort study found a high risk of end-stage kidney disease associated with acromegaly.
    Kidney Int. 2023 Jul 23:S0085-2538(23)00501-X. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available

  6. VOGT L, Marques FZ, Fujita T, Hoorn EJ, et al
    Novel mechanisms of salt-sensitive hypertension.
    Kidney Int. 2023 Jul 14:S0085-2538(23)00493-3. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available

  7. FENG W, Guan Z, Ying WZ, Xing D, et al
    Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease.
    Kidney Int. 2023 Jul 7:S0085-2538(23)00489-1. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available

    June 2023
  8. FAUCON AL, Fu EL, Stengel B, Mazhar F, et al
    A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.
    Kidney Int. 2023 Jun 15:S0085-2538(23)00418-0. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available

    May 2023
  9. SHOLOKH A, Walter S, Marko L, McMurray BJ, et al
    Mutant phosphodiesterase 3A protects the kidney from hypertension-induced damage.
    Kidney Int. 2023 May 25:S0085-2538(23)00389-7. doi: 10.1016/j.kint.2023.

  10. SMITH JP, Sequeira-Lopez MLS, Gomez RA
    A novel role for the histone modifier PRDM6 and an opportunity to understand hypertension.
    Kidney Int. 2023 May 24:S0085-2538(23)00385-X. doi: 10.1016/j.kint.2023.

    January 2023
  11. FERNANDES-ROSA FL, Boulkroun S, Fedlaoui B, Hureaux M, et al
    New advances in endocrine hypertension: from genes to biomarkers.
    Kidney Int. 2023 Jan 13:S0085-2538(23)00009-1. doi: 10.1016/j.kint.2022.
    PubMed     Abstract available

    How should blood pressure be measured? Con: the peripheral blood pressure is sufficient.
    Kidney Int. 2023;103:38-40.

    Value of measuring central blood pressure in clinical practice.
    Kidney Int. 2023;103:34-38.

    December 2022
    Blood pressure effects of sodium transport along the distal nephron.
    Kidney Int. 2022;102:1247-1258.
    PubMed     Abstract available

    November 2022
  15. SHANKLAND SJ, Wessely O
    Zoning in on podocytes.
    Kidney Int. 2022;102:966-968.
    PubMed     Abstract available

  16. HARUHARA K, Kanzaki G, Sasaki T, Hatanaka S, et al
    Associations between nephron number and podometrics in human kidneys.
    Kidney Int. 2022;102:1127-1135.
    PubMed     Abstract available

    October 2022
  17. GARIMELLA PS, du Toit C, Le NN, Padmanabhan S, et al
    A genomic deep field view of hypertension.
    Kidney Int. 2022 Oct 29. pii: S0085-2538(22)00911.
    PubMed     Abstract available

    July 2022
  18. SURAPANENI A, Schlosser P, Zhou L, Liu C, et al
    Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00547.
    PubMed     Abstract available

    June 2022
  19. TOMASZEWSKI M, Morris AP, Howson JM, Franceschini N, et al
    Kidney omics in hypertension - from statistical associations to biological mechanisms and clinical applications.
    Kidney Int. 2022 Jun 8. pii: S0085-2538(22)00442.
    PubMed     Abstract available

  20. NODA R, Han W, Shibagaki Y, Yazawa M, et al
    Renovascular hypertension secondary to massive iliopsoas hematoma.
    Kidney Int. 2022;101:1304.

  21. SUBBIAH A, Bhowmik D
    KDIGO recommendations on blood pressure management in chronic kidney disease.
    Kidney Int. 2022;101:1299.

    February 2022
  22. IX JH, Thomson CRV, Cheung AK, Mann JFE, et al
    Response to "Diagnosis and Treatment of Arterial Hypertension 2021".
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00108.

  23. OTT C, Schmieder RE
    Response to: "Response to "Diagnosis and Treatment of Arterial Hypertension 2021".
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00109.

    December 2021
  24. TURNER M, Staplin N
    UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease.
    Kidney Int. 2021;100:1168-1170.
    PubMed     Abstract available

    October 2021
  25. OTT C, Schmieder RE
    Diagnosis and Treatment of Arterial Hypertension 2021.
    Kidney Int. 2021 Oct 29. pii: S0085-2538(21)01023.
    PubMed     Abstract available

    Ultrasound renal denervation for hypertension: impact of the RADIANCE-HTN-TRIO trial on future management of resistant hypertension.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00927.

    August 2021
    Salbutamol and salt-sensitive hypertension.
    Kidney Int. 2021;100:272-275.
    PubMed     Abstract available

    Targeting TMEM16A-encoded Ca(2+)-activated Cl(-) channels: a new paradigm for antihypertensive therapy?
    Kidney Int. 2021;100:269-272.
    PubMed     Abstract available

    April 2021
  29. SANTORIELLO D, Bomback AS, Kudose S, Batal I, et al
    Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
    Kidney Int. 2021 Apr 12. pii: S0085-2538(21)00379.
    PubMed     Abstract available

  30. LUO S, Feofanova EV, Tin A, Tung S, et al
    Genome-wide association study of serum metabolites in the African American Study of Kidney Disease and Hypertension.
    Kidney Int. 2021 Apr 7. pii: S0085-2538(21)00361.
    PubMed     Abstract available

  31. CIL O, Chen X, Askew Page HR, Baldwin SN, et al
    A small molecule inhibitor of the chloride channel TMEM16A blocks vascular smooth muscle contraction and lowers blood pressure in spontaneously hypertensive rats.
    Kidney Int. 2021 Apr 6. pii: S0085-2538(21)00360.
    PubMed     Abstract available

    March 2021
  32. FOTI KE, Wang D, Chang AR, Selvin E, et al
    Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Kidney Int. 2021;99:686-695.
    PubMed     Abstract available

    November 2019
  33. CHIANG HP, Chiu YW, Lee JJ, Hung CC, et al
    Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.
    Kidney Int. 2019 Nov 7. pii: S0085-2538(19)31114.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.